Top 20 Global Biopharma Companies See 2% Growth
The biopharmaceutical industry demonstrated signs of recovery in the third quarter (Q3) of 2024, with increased investor optimism following the interest rate cuts by the US Federal Reserve in September 2024. As a result, the top 20 global biopharmaceutical companies reported an upturn of 2% in aggregate market capitalization from $4.2 trillion as on 30 June 2024...
APAC deal volume dips 4.8% YoYÂ
A total of 11,808 deals (mergers & acquisitions (M&A), private equity and venture financing deals) were announced in the Asia-Pacific (APAC) region during January to October 2024, which was a year-on-year (YoY) decline of 4.8% compared to the 12,406 deals announced during the same period in 2023, according to GlobalData, a leading data and analytics company.
An analysis of GlobalData’s Deals Database revealed...
Is the Dow Jones's and other indices' decline a symptom of global economic turmoil?
On Monday, the Dow Jones Index experienced a significant drop of...
China Stocks Ended Mixed on Lack of Positive Catalysts
Market analysis on behalf of Milad Azar Market Analyst at XTB MENA
Chinese stocks experienced a mixed...
Bitcoin’s 5-year ROI outperforms major banks stocks’ by over 4000% on average
Bitcoin's growth in recent years has resulted in investors reaping significant returns with...
Combined Market Cap of World's Largest Airlines Plunges by $12B as COVID-19 Cases Climb
Airline companies are still far from pre-pandemic profit and sales as...
Technology sector stocks most profitable with 30% average ROI in the last 12 months
Data gathered by Buyshares.co.uk indicates that the technology sector stocks are most profitable...
